NEW YORK (GenomeWeb News) – Sequenom reported after the close of the market Thursday that its fourth-quarter revenues more than doubled year over year, as the firm edged out the Wall Street estimate on the top line.

Despite the strong revenue growth, Sequenom's shares fell in early Friday trade as the firm missed estimates on the bottom line and gave limited information on test volume and reimbursement expectations for its flagship prenatal test.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: ancestry and admixture in Brazilians, characterization of novel double-stranded RNA mycovirus, and more.

Researchers report that what scents someone picks up can reflect their complement of immune genes.

The New York Times examines ethics and China's push to lead biomedical research.

At her blog, Sally Rockey dives into National Institutes of Health funding data.

Jul
14
Sponsored by
Agilent Technologies

This online seminar will outline a recent example of the use of molecular barcoding in combination with next-generation sequencing to detect somatic mosaicism in cancer patients.